… minimal residual disease after treatment to predict disease relapse in patients with AML has
been explored, but assessment of molecular minimal residual disease … only a few leukemia-…

… Our understanding of heterogeneity and the underlying disease biology of acute myeloid
leukaemia (AML) has been greatly deepened by modern laboratory advances 1,2,3,4 that have …

… has become apparent that acute myeloid leukemia (AML) is … transplant practice in this
disease remains largely based on … levels of leukemia (ie, minimal residual disease, MRD) using …

… (MRD), defined as any measurable disease or leukemia … AML is lagging behind acute
lymphoblastic leukemia with … disadvantaged compared with acute lymphoblastic leukemia in that …

… In this view, measure of minimal residual disease (MRD) promises to be an efficient tool to
establish on an individual basis the patient's leukemia's susceptibility to treatment, enhancing …

… minimal residual disease (MRD) and to guide risk-adapted management in acute myeloid
leukemia (AML). … Treatment of patients with acute myeloid leukemia (AML) increasingly follows …

… High prognostic impact of flow cytometric minimal residual disease detection in acute
myeloid leukemia: data from the HOVON/SAKK AML 42A study. J Clin Oncol. 2013;31(31):3889–97…

… Both presence of minimal residual disease (MRD) and achievement of complete remission
(… CR after induction therapy predict relapse in acute myeloid leukemia (AML). These results …

… Treatment of acute myelogenous leukemia (AML) over the past four decades remains … It is
thought that relapse in AML is in part driven by minimal residual disease (MRD) that remains in …

… use of minimal residual disease measurements in “real-… minimal residual disease will soon
become the new standard for evaluating response in the treatment of acute myeloid leukemia…